Open AccessCreatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study
Author(s) -
Polyana Monteiro,
Isidro Sanz Pérez,
Judit Pich,
JM Gatell,
Estebán Martínez
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks416
Subject(s) - raltegravir , medicine , antiretroviral therapy , creatine kinase , incidence (geometry) , human immunodeficiency virus (hiv) , cohort , cohort study , integrase inhibitor , immunology , viral load , physics , optics
To evaluate the incidence and risk factors for significant creatine kinase elevation in HIV-1-infected patients who were prescribed a raltegravir-containing antiretroviral therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom